Introduction
17q21.31 microdeletion syndrome is a recently delineated recognizable dysmorphic syndrome which arises due to misalignment of low-copy number repeat sequences and the unusual genomic architecture at this locus: an inversion polymorphism is present in 20% of the Caucasian population (Koolen et al., 2006; Shaw-Smith et al., 2006) . Currently underdiagnosed because of its only recent recognition, it is thought that 1 in 16 000 individuals may be affected by this syndrome (Koolen et al., 2008) . Haploinsufficiency for the microtubule-associated protein tau (MAPT) gene within the deleted region seems to be the most likely cause for the learning disabilities and other anomalies seen in this condition (Koolen et al., 2006; Shaw-Smith et al., 2006) . Cardio-facio-cutaneous (CFC) syndrome was first described in 1986 (Reynolds et al., 1986) , and shows considerable overlap with other neuro-cardio-facio-cutaneous syndromes, particularly Noonan and Costello syndromes. The reason for these observed overlaps is that the protein products of all genes known to be mutated in these conditions interact within the RAS-mitogen-activated protein kinase (MAPK) pathway (Burkitt Wright and Kerr, 2010 ). An earlier published series of 17q21.31 microdeletion patients included several with features reminiscent of Noonan syndrome, including one in whom this diagnosis was thought sufficiently likely for Noonan syndrome genes to have been tested (Tan et al., 2009) . Several individuals in that series also had features of ectodermal dysplasia, three of 11 individuals had pulmonary stenosis, and other cardiac lesions were also described (Tan et al., 2009) . Normal birth weight and relative macrocephaly are features that seem to be present in the majority of patients both with 17q21.31 microdeletion (Tan et al., 2009) and RAS pathway disorders (Burkitt Wright and Kerr, 2010) . Variable degrees of developmental delay have been noted in patients with 17q21.31 microdeletion, and this spectrum is still liable to expansion. Similarly, patients with CFC syndrome may have variable degrees of intellectual disability (Burkitt Wright and Kerr, 2010) .
Patients Patient 1
A 21-year-old male patient was born at term, weighing 3.4 kg. He required tube feeding in the first 3 weeks of life and was hypotonic. Growth has continued between the 25th and 50th percentile curves, his current height being 176 cm. He has a predominantly truncal fat distribution. His head circumference has followed the 97th percentile, and is now 57.6 cm. He has had unusual skin since birth, with redundant skin folds, coarse hair with a chaotic growth pattern and keratosis pilaris. He has always been more highly pigmented than other family members. A very large number of naevi developed all over his body through childhood and he also has several café au lait patches. He has slight coarsening of his facial features, including a broad nose, thick lips and posteriorly rotated ears with large lobes, as shown in Fig. 1a and e. He has severe learning difficulties and longstanding epilepsy, which is well controlled on carbemazepine, but also had challenging behaviour for which he has been prescribed thioridazine in addition. He also has strabismus, difficulty in chewing (from weakness of masseters) and subluxed patellae. His hands were fleshy with deep skin creases ( Fig. 1i ). Endocrinological assessment was made because of hyperpigmentation and showed normal short synacthen response and oral glucose tolerance. Chromosome analysis showed a 46, XY karyotype, with normal fluorescence insitu hybridization (FISH) for Prader-Willi and Smith-Magenis syndromes. Cranial computed tomography scan and muscle biopsy were normal. Transferrin isoelectric focusing and steroid sulphatase activity were normal, as was a urinary mucopolysaccharide screen.
Patient 2
A 22-year-old male patient weighed 2.8 kg at birth by caesarian delivery at 41 weeks' gestation for breech presentation. He was admitted to the special care unit on day 2 of life with poor feeding and stridor because of laryngomalacia. Feeding difficulties continued until weaning. A small secundum atrial septal defect and mild pulmonary stenosis were shown on echocardiography. He had undescended testes and hypospadias, which were surgically corrected, and several urinary tract infections. A small umbilical hernia resolved spontaneously. He had joint laxity. Mild delay of motor milestones was present, but speech delay was marked at the age of 5 years, he was still using only single words. At the age of 8 years, he could put three words together. His height (180 cm) and weight (75 kg) lie between the 50 and 75th percentiles, whereas his head circumference was on the 91st percentile (59.7 cm). Pubertal development was normal. At the age of 16 years, he sat for several national school examinations, attaining average grades in some. He currently lives with his parents, works part time in a supermarket and attends adult education life skills courses. On review at the age of 20 years, his coarse facial features, as shown in Fig. 1b and f, were more marked than in childhood, in particular his broad nose and thick lips. Naevi were remarkably numerous over his entire body. His karyotype was normal, 46, XY.
Patient 3
A 16-year-old female patient has short stature and mildto-moderate learning difficulties. She had a birth weight of 2.3 kg at 41 weeks' gestation, and placental insufficiency was suspected. She would not breast feed, but had established bottle feeds by day 10 of life. Joint laxity and muscular hypotonia were prominent in infancy and early childhood. She first walked at the age of 20 months. She had recurrent chest infections in the first 5 years of life, but has been in good health since, with normal pubertal development. She has coarse textured, dry hair, relatively coarse facial features, as shown in Fig. 1c and g, and an unusual thickened hyperpigmented area of skin on her upper abdomen, as shown in Fig. 1m . She is developing naevi, particularly over her face and trunk, and has a mild pectus deformity. Her karyotype is 46, XX. Her height remains around the third percentile, and her head circumference of 55.4 cm is on the 50th percentile.
Patient 4
A 28-year-old female patient was born at term, weighing 2.78 kg. She had global developmental delay; first unsupported sitting was at the age of 2.5 years and walking at the age of 3 years. She spoke no words until the age of 14 years. She was initially referred to a genetics clinic at the age of 12 years. She was noted to have generalized hyperpigmentation for which no cause could be identified. Porphyria, haemochomatosis and excess of adrenocorticotropic hormone were excluded. Optic atrophy, left pelvi-ureteric junction obstruction and delayed bone age were also present. Her occipito-frontal circumference measured 51 cm (third percentile) and height 109 cm ({0.4th percentile). She has sensorineural hearing loss and had chronic serous otitis media. She developed pneumonia and a pericardial effusion at the age of 11 years, the latter being persistent till the age of 15 years, but stable. Swollen proximal interphalangeal joints were noted from the age of 14 years, as were several café au lait patches. A diagnosis within the Noonan/CFC/Watson spectrum was therefore considered at this stage. Puberty was delayed, with pelvic ultrasound at the age of 15 years showing a small uterus and delayed ovarian development.
Menarche was at the age of 17 years. MRI brain scanning showed left medial temporal sclerosis and a small hippocampus. At the age of 19 years, a thoracic scoliosis and limitation of elbow extension were noted. At the age of 28 years, her height is 131.2 cm ({0.4th percentile), occipito-frontal circumference is 51.5 cm (0.4th percentile) and weight is 35.3 kg (< 0.4th percentile). She has a prematurely aged skin appearance. She has a broad nasal tip, upslanting palpebral fissures and a long face with a thin upper lip ( Fig. 1d and h) . Her palmar and plantar creases are deep (see Fig. 1l and n), and she has recently been diagnosed with cataract. In addition, a small larynx with a small anterior laryngeal web has been noted. Her karyotype is 46, XX. Chromosome breakage studies, creatine kinase, urine amino acids and mucopolysaccharide screen, white cell enzymes, very long-chain fatty acids, copper levels, sweat test and thyroid function were also normal, as was FISH testing for deletion at the NF1 locus.
Methods and results
Mutation analysis by sequencing of all exons of BRAF, KRAS, HRAS, MEK1 and MEK2, in which CFCassociated mutations have been reported, showed no such mutation in patient 1. Array comparative genomic hybridization (aCGH), using the Genechip SNP6.0 array (Affymetrix, Santa Clara, California, USA), was carried out on patients 1 and 2, and showed deletions at 17q21.31, of 639 kb in patient 1 and 519 kb in patient 2, as shown in Fig. 2 . These deletions included the critical region identified for the condition as indicated, overlapping as they do with those earlier reported in 17q21.31 microdeletion syndrome (Koolen et al., 2008) . In addition, patient 1 was found to have a 2.4 Mb duplication of 22q11.21 (data not shown). His 17q21.31 microdeletion and 22q11.21 duplication were confirmed by multiplex ligation probe analysis using the multiplex ligation-dependent probe amplification P245 kit (MRC Holland, Amsterdam, the Netherlands). Patient 2 was noted to have an additional copy number variant, a duplication of 17q21.31, just distal to his deletion, as shown in Fig. 2 .
In patients 3 and 4, the del 17q21.31 microdeletion phenotype was recognized clinically at a review appointment, and FISH was then used to show deletion of MAPT. In patient 4, deletion breakpoints of 17q21.31, 41107486 41610161, were indicated by the heterozygous loss of 26 oligonucleotide probes on aCGH, giving an approximate deletion size of 502 kb, as represented in Fig. 2 . The denovo nature of the deletions in patients 2 and 3 was confirmed by normal FISH results in both parents, whereas parental samples were not available for patients 1 and 4.
Discussion
The phenotypic features of 17q21.31 microdeletion and CFC syndrome are compared in Table 1 . A large number of naevi, in conjunction with other cutaneous features, coarse facial characteristics, relative macrocephaly, poor feeding in infancy and significant learning disabilities, led to the clinical suggestion of CFC syndrome in the four patients described here. In addition, the striking skin appearance because of increased pigmentation, sufficient to warrant endocrine investigation, in patients 1 and 4 in this series is another distinctive feature that is reminiscent of RAS-MAPK-pathway disorders. It bears particular resemblance to the bronzed skin reported in many patients with Costello syndrome, including those in Costello's original report (Costello, 1977) .
22q11.2 duplications, as identified in patient 1, have been associated with a diverse range of features, but overall phenotypes are most commonly mild, and duplications are also frequently inherited from phenotypically normal parents (Firth, 2009 ). Although it is not possible to exclude increased copy number at 22q11.2 as a contributor to patient 1's clinical presentation, his features did not correlate to those commonly reported in association with this duplication. This is in contrast to his marked similarities to other individuals with 17q21.31 microdeletion syndrome.
The phenotypic similarity of each of the four individuals described here to patients with molecularly proven CFC syndrome raises the question as to whether the 17q21.31 locus could harbour a gene or genes implicated in this condition. Such genes causing a phenotype by deletion Diagram of the 17q21.31 locus, with deletions in patients 1, 2 and 4 is shown. Light grey indicates deleted material, whereas dark grey is adjacent duplicated material in patient 2, in this region, rich in copy number variants. The critical region for the deletion phenotype is shown at the top of the figures. MAPT, microtubule-associated protein tau; SNP, single nucleotide polymorphism.
would suggest haploinsufficiency as a mechanism, with loss of an allele encoding a protein which inhibits RAS-MAPK-pathway activity perhaps being sufficient to cause pathway overactivation, analogous to the mechanism by which inactivating mutations in NF1 cause neurofibromatosis type I (Huson, 2008) . The commonly deleted area on 17q21.31 spans six known genes. At present none of these are known to interact with the RAS-MAPK pathway, but two, CRHR1 and MAPT, are each highly expressed in brain, and therefore represent prime candidates for causing the neurological phenotype seen in 17q21.31 microdeletion (Koolen et al., 2008) .
CFC syndrome shows considerable variability in the severity of learning disability, physical and behavioural problems shown by affected individuals. A broad spectrum of capabilities is also observed in patients with 17q21.31 microdeletion, as shown by the four patients described here. The variable severity and manifestations of both CFC syndrome and 17q21.31 microdeletion means that there may be a significant number of individuals for whom both conditions should be considered within the differential diagnosis.
Conclusion
The diagnosis of 17q21.31 microdeletion may be achievable clinically in some patients, but it may not be easy to recognize in all. Large numbers of naevi and/or pigmentary skin changes, reminiscent of those seen in patients with CFC syndrome, and like those discussed here, should prompt consideration of testing for 17q21.31 microdeletion by FISH, multiplex ligation-dependent probe amplification or aCGH, particularly when a large, pear-shaped or tubular nose is also present. Patients in whom a clinical diagnosis of CFC syndrome has been suggested earlier, or those in whom no mutation has been found in any of the known genes for CFC syndrome, should also be reassessed in the light of this possibility.
These findings show the particular value of long-term clinical review of patients without a molecular diagnosis, and suggest that aCGH should be considered in all patients with a clinical diagnosis of CFC syndrome who do not have a mutation in known CFC genes. The phenotypic similarities between several patients with 17q21.31 microdeletions and those with molecularly confirmed Numerators are number of patients with the feature, denominators are the number of patients on whom the data was available. ASD, atrial septal defect; CFC, cardio-facio-cutaneous; OFC, occipito-frontal circumference; SD, standard deviation; VSD, ventricular septal defect.
CFC syndrome suggest the possibility that one or more genes at 17q21.31 might influence RAS-MAPK-pathway activity in some way.
